High-dose radiotherapy to 78 Gy with or without temozolomide for high grade gliomas.

Watkins, John M; Marshall, David T; Patel, Sunil; Giglio, Pierre; Herrin, Amy E; Garrett-Mayer, Elizabeth; Jenrette, Joseph M

Watkins, John M; Marshall, David T; Patel, Sunil; Giglio, Pierre; Herrin, Amy E; Garrett-Mayer, Elizabeth; Jenrette, Joseph M.

Affiliation

Watkins JM; Department of Radiation Oncology, Medical University of South Carolina, Charleston, SC 29425, USA.

J Neurooncol ; 93(3): 343-8, 2009 Jul.

Article in En | MEDLINE | ID: mdl-19142584

Subject(s)

Antineoplastic Agents, Alkylating/administration & dosage; Brain Neoplasms/therapy; Dacarbazine/analogs & derivatives; Glioma/therapy; Radiotherapy/methods; Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms/pathology; Combined Modality Therapy; Dacarbazine/administration & dosage; Dose-Response Relationship, Radiation; Glioma/pathology; Humans; Kaplan-Meier Estimate; Middle Aged; Radiation Dosage; Retrospective Studies; Temozolomide; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiotherapy / Brain Neoplasms / Antineoplastic Agents, Alkylating / Dacarbazine / Glioma Type of study: Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged Language: En Journal: J Neurooncol Year: 2009 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google